Top 50 Life Science Angel Investors in Europe (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
11 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Nadav Rosenberg
Angel
|
5 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Software, Biotechnology, Artificial Intelligence | $1.1M–$21M |
|
Annie Vereecken
Angel
|
3 | Belgium | Seed, Series A, Venture - Series Unknown | Medical, Biotechnology, Hospital | $2M–$30M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Stefano Bernardi
Angel
|
3 | Italy, United Kingdom, Canada | Seed, Pre-Seed | Blockchain, Software, Biotechnology | $100k–$18M |
|
Jeff Dean
Angel
|
3 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Information Technology | $500k–$60M |
|
Jude Gomila
Angel
|
3 | United States, United Kingdom, India | Seed, Pre-Seed, Angel | Software, Information Technology, Artificial Intelligence | $70k–$4.7M |
|
Ed Parkinson
Angel
|
2 | United Kingdom | Seed | Health Care, Life Science, Biotechnology | $1.9M–$3M |
|
Mark Evans
Angel
|
2 | United Kingdom, United States, The Netherlands | Series A, Seed, Series C | Retail, Fashion, Software | $1.4M–$68M |
|
Sauli Törmälä
Angel
|
2 | Finland | Seed | Life Science, Biotechnology | $598k–$1.3M |
|
Sylvain Zimmer
Angel
|
2 | France, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, SaaS, Real Estate | $118k–$10M |
|
Paul Wicks
Angel
|
2 | United Kingdom, United States, Japan | Seed, Pre-Seed, Series A | Software, Wellness, E-Commerce | $539k–$11M |
|
Ersin Pamuksüzer
Angel
|
2 | Turkey, Germany | Seed, Series A | Education, Life Science, Virtual Reality | $300k–$500k |
|
Dr Guntard Gutmann
Angel
|
2 | Germany | Convertible Note, Venture - Series Unknown | Health Care, Life Science, Therapeutics | |
|
Albert Wenger
Angel
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Software, Internet, Analytics | $650k–$30M |
|
Balaji Srinivasan
Angel
|
2 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $650k–$28M |
|
Holger Hübner
Angel
|
2 | Germany | Seed, Pre-Seed | B2B, SaaS, Audio | $177k–$1.1M |
|
Robert Kopple
Angel
|
2 | United States, United Kingdom | Convertible Note, Venture - Series Unknown | FinTech, Finance, Life Science | $3.3M–$4.8M |
|
Mati Staniszewski
Angel
|
2 | United States, United Kingdom, Sweden | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $2M–$75M |
|
Luc Vauterin
Angel
|
2 | Belgium | Seed, Series A | Software, Analytics, Life Science | |
|
Nicholas Edwards
Angel
|
2 | United Kingdom | Seed, Venture - Series Unknown | Medical, Health Care, Life Science | |
|
Leena Niemistö
Angel
|
2 | Finland, United States | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Software, E-Commerce | $306k–$3.5M |
|
Nico Wittenborn
Angel
|
2 | United States, Germany, France | Series A, Seed, Series B | Apps, Software, Mobile Apps | $1.6M–$88M |
|
Carsten Maschmeyer
Angel
|
2 | Germany, Austria, Switzerland | Seed, Angel, Series A | Software, Artificial Intelligence, Information Technology | $89k–$24M |
|
Bradley Horowitz
Angel
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $150k–$36M |
|
Edward Lando
Angel
|
2 | United States, United Kingdom, France | Seed, Pre-Seed, Series A | Software, FinTech, Artificial Intelligence | $125k–$31M |
|
Pierre Drion
Angel
|
2 | Belgium | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Life Science | $8.6M–$23M |
|
Charlie Songhurst
Angel
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $500k–$24M |
|
Tim Davis
Angel
|
2 | United States, United Kingdom, Germany | Series A, Series B, Seed | Health Care, Medical, Biotechnology | |
|
Darrin Disley
Angel
|
2 | United Kingdom | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Big Data | $462k–$3.7M |
|
Aidan Gomez
Angel
|
2 | United States, United Kingdom, Canada | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Generative AI | $1.8M–$12M |
|
Damien Lane
Angel
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | Software, SaaS, Health Care | $532k–$16M |
|
Bertrand Jacquelot
Angel
|
2 | France, United States | Pre-Seed, Seed, Angel | Food and Beverage, E-Commerce, Information Technology | $120k–$7.8M |
|
Thor Bjorgolfsson
Angel
|
2 | United Kingdom, Germany | Seed, Series A, Series C | Big Data, TV, B2B | $26M–$26M |
|
Andrew Nutter
Angel
|
2 | France, United Kingdom, United States | Seed, Pre-Seed, Venture - Series Unknown | Software, SaaS, FinTech | $550k–$4.9M |
|
Matt Clifford
Angel
|
2 | United Kingdom, United States, India | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, FinTech | $55k–$34M |
|
Nadav Ben-Chanoch
Angel
|
2 | United States, France, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $120k–$30M |
|
Simon Galbraith
Angel
|
2 | Croatia, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Life Science | |
|
Jan Hruska
Angel
|
2 | United Kingdom | Seed, Venture - Series Unknown | Medical, Health Care, Life Science | |
|
Paul Forster
Angel
|
2 | United Kingdom, Germany, United States | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $1M–$26M |
|
Bernard Majoie
Angel
|
2 | France, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Care | $1.4M–$2.7M |
|
Ian Hogarth
Angel
|
2 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $698k–$43M |
|
Michael Novogratz
Angel
|
2 | United States, India, Germany | Seed, Series A, Series B | Blockchain, Cryptocurrency, FinTech | $1.1M–$150M |
|
David Helgason
Angel
|
2 | United States, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Artificial Intelligence | $242k–$30M |
|
Nitin Sharma
Angel
|
1 | India, United States, Germany | Pre-Seed, Seed, Grant | Financial Services, Software, Information Technology | $165k–$11M |
|
Michelle Tempest
Angel
|
1 | United Kingdom | Seed, Series A | Health Care, Cannabis, Life Science | |
|
Sven Fund
Angel
|
1 | Germany, Italy, Ireland | Seed, Pre-Seed | Publishing, Events, Digital Media | $250k–$3M |
|
Keith Willey
Angel
|
1 | United Kingdom, Spain, Portugal | Seed, Angel, Pre-Seed | Software, Gaming, Real Estate | $446k–$6.5M |
|
Mikael Lonn
Angel
|
1 | Sweden | Series A | Medical, Life Science, Biotechnology | |
|
David Lucas
Angel
|
1 | United Kingdom | Seed | Software, Life Science, Biotechnology | |
| Access all 50 angel investors in Europe Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 16
- Round size: Seed $1.1M–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Lindus Therapeutics — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Annie Vereecken
Show more...Investment focus
- Industry: Medical, Biotechnology, Hospital
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $2M–$6M; Series A $9.2M–$30M; Venture - Series Unknown $4.1M–$8.8M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Blockchain, Software, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, Canada
Investor stats
- Total investments: 18
- Round size: Seed $100k–$18M; Pre-Seed $874k–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Freatic — Building the monetization layer for your alpha
- Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
- Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Seed $2.5M–$34M; Pre-Seed $500k–$3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Grubel — Grubel envisions a future in which each substance creates its own AI, one that understands its surroundings and performs the best work possible within them.
- G5 Labs — G5 is the semantic abstraction layer that makes AI-native software development compilable, mergeable, and governable for enterprises.
- Wafer — Wafer is an AI optimization platform that automatically accelerates AI models by generating efficient custom GPU kernels.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$4.7M; Angel $70k–$1.3M; Pre-Seed $1M–$2.9M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Clara — Clara is an AI-powered primary care doctor.
- Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Ed Parkinson
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $1.9M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more...Investment focus
- Industry: Retail, Fashion, Software
- Stage:Series A, Seed, Series C
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 37
- Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$68M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
- Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Seed $598k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.
Show more...Investment focus
- Industry: Software, SaaS, Real Estate
- Stage:Seed, Pre-Seed, Angel
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 27
- Round size: Seed $740k–$10M; Angel $400k–$500k; Pre-Seed $118k–$2.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
- TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.
Show more...Investment focus
- Industry: Software, Wellness, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 17
- Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.7M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
- Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
- Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
Ersin Pamuksüzer
Show more...Investment focus
- Industry: Education, Life Science, Virtual Reality
- Stage:Seed, Series A
- Geography: Turkey, Germany
Investor stats
- Total investments: 5
- Round size: Seed $300k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aposto — All-in-one media service currently based in Istanbul, Turkey.
- VRLab Academy — VRLab Academy | Virtual Experiments
Dr Guntard Gutmann
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Convertible Note, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more...Investment focus
- Industry: Software, Internet, Analytics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 111
- Round size: Seed $650k–$16M; Series A $2.5M–$23M; Series B $4.3M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
- Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
- Phlair — 77NEKO merupakan acces situs utama untuk permainan viral yang tentunya paling kekinian dan bukan hanya itu dengan memanfaatkan fitur yang tersedia pemain dapat berpeluang cuan lebih besar dan menjadi sultan.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 276
- Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
- Physical Superintelligence — Physical Superintelligence develops physical superintelligence systems that use AI-driven research to study physics, engineer physical systems, and explore new physical laws. Its approach combines human scientists with virtual physicists that conduct autonomous research campaigns covering hypothesis development, verification, experimentation,engineering, and deployment. The company focuses initially on the physical infrastructure underlying AI, including energy, materials, computation, sensing, and manufacturing.
Holger Hübner
Show more...Investment focus
- Industry: B2B, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 5
- Round size: Seed $560k–$1.1M; Pre-Seed $177k–$342k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Robert C. Kopple is based out of Vancouver, Ontario, and is the Partner of Kopple, Klinger & Elbaz. Robert previously worked at Gelum Resources as a Board of Directors. Robert C. Kopple attended New York University.
Show more...Investment focus
- Industry: FinTech, Finance, Life Science
- Stage:Convertible Note, Venture - Series Unknown
- Geography: United States, United Kingdom
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $3.3M–$4.8M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Tradier — Tradier brings traders, developers, and partners together with tools, infrastructure, and pricing for trading stocks, options, futures, crypto, and forex, or build on our API.
- ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Mati Staniszewski is the Co-Founder of ElevenLabs.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Sweden
Investor stats
- Total investments: 22
- Round size: Seed $4.5M–$11M; Pre-Seed $2M–$20M; Series A $16M–$75M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- imagi — Programming has never been this much fun! Learn to create with code, share your designs with friends on the imagiLabs app and customize your imagiCharm - a fun, easy-to-use, colorful, and educational toy for girls. Imagine it. Code it. Wear it.
- Dwelly — Dwelly acquires and partners with independent UK lettings agencies, helping owners exit smoothly, profitably and on their terms. Get a free agency valuation.
- Arrakis Security — Secure the enterprise agents where they're deployed. Total visibility, governance, and remediation for the autonomous workforce.
Luc Vauterin - Board Member @ ONTOFORCE
Show more...Investment focus
- Industry: Software, Analytics, Life Science
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ONTOFORCE — ONTOFORCE helps life sciences organizations accelerate research and drug development for improved patient outcomes by unlocking hidden insights from data. Founded on semantic technology and an ontology-based knowledge graph, their flagship product, DISQOVER, is a data and knowledge platform developed specifically for the life sciences industry.DISQOVER seamlessly connects an organization’s internal, siloed data with licensed data and public data in one easy-to-use, customizable platform, enabling efficient data exploration and analysis. DISQOVER has over 10,000 users across the globe and is deployed by many leading pharmaceutical and biotechnology companies. Users include scientific researchers, bioinformaticians, data scientists, and many other roles. ONTOFORCE is headquartered in Ghent, Belgium and has a secondary office in the United States in Cambridge, Massachusetts. Learn more about ONTOFORCE at ontoforce.com and try DISQOVER at disqover.com.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Leena Niemistö
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 19
- Round size: Seed $306k–$3.2M; Venture - Series Unknown $2.2M–$3.5M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
- Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Industry: Apps, Software, Mobile Apps
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, France
Investor stats
- Total investments: 47
- Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Mirage — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Angel, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 84
- Round size: Seed $116k–$4.2M; Angel $89k–$548k; Series A $1.6M–$24M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ivyclip — Ivyclip makes flexible, pain-free hair claws from medical-grade materials.
- Finperks — finperks is a prepaid infrastructure API for banks, neobanks, HR platforms, etc. in Europe. Access 1000+ brands across 30+ countries. Simplify contracts, settlements, and integrations to scale your prepaid, cashback, and employee benefits solutions.
- admark.ai — admark.ai combines cutting-edge AI language models with social media data
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 137
- Round size: Seed $150k–$18M; Pre-Seed $500k–$6.6M; Series A $7.5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Audioshake — AudioShake makes audio interactive, customizable, and accessible by using AI to separate sound recordings into their component parts and stems.
- Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 581
- Round size: Seed $950k–$6.3M; Pre-Seed $125k–$3.3M; Series A $5M–$31M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera - AI CAPTCHA That Knows You're Human
- Allonic — Allonic is a robotics hardware company pioneering 3D Tissue Braiding, a new manufacturing platform for producing integrated, compliant, bio-inspired robotic bodies through a single, fully automated production process. By eliminating assembly-heavy designs and supply-chain complexity, Allonic enables significantly faster iteration, lower costs, andsafer, more dexterous robots to be built. Originally founded from Hungary and operating internationally with a US HQ and a growing team of 15, Allonic is building the hardware foundation for the next generation of intelligent machines.
- Heywa Labs — Two products, one engine. Heywa Studio for businesses, Heywa for anyone with a question worth following.
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 5
- Round size: Series A $8.6M–$16M; Series B $18M–$23M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 258
- Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.1M; Series A $2.9M–$24M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zeit AI — Zeit AI, founded by former Palantir engineers, generates a structured data base atop your tabular data files which you can query using natural language. For example, you suspect an efficiency in your organisation and you have a bunch of data files, instead of reading through all of them one by one in excel, you explore them in Zeit AI. Theycurrently offer a two-week pilot program where their engineers develop tailored solutions for data challenges involving CSV, Excel, or PDF files.
- Mantic — Mantic is a world-class technical team on a mission to solve the next AI grand challenge: predicting global events with superhuman accuracy, and deploying this capability to power radically improved decision-making in business and government.
- Pilgrim — Pioneering a biologically enhanced future for humanity.
Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 10
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- MycoMedica Life Sciences, PBC — Psychedelic Medicines
Darrin Disley is based out of Cambridge, Cambridgeshire, and is the Executive Chairman and Director of Cardiogeni. Darrin previously worked at Mogrify as Chief Executive Officer, Director, and Investor. Darrin Disley attended the University of Cambridge.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Big Data
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 5
- Round size: Seed $462k–$3.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- bit.bio — Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development. The company uses a precision cell programming system to convert stem cells into defined human cell types and supplies a portfolio of reprogrammed cells, custom cell development services, and research-readyhuman cell models for scientific and pharmaceutical use. Bit.bio also supports integration of its products into partner research ecosystems and offers platform capabilities that help identify transcription factors for specific cell states. Its focus includes enabling scalable access to human cell models for experiments, screening workflows, and therapeutic investigation.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Generative AI
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 17
- Round size: Seed $2.8M–$12M; Pre-Seed $1.8M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cheiron — Cheiron is a domain-tuned AI engine for biomedical and pharmaceutical professionals, delivering fast, verifiable, and context-aware insights across research, clinical, medical affairs, and regulatory workflows.
- Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
- General Magic — General Magic helps insurance teams handle every customer conversation, underwriting decision, and quote in one place. AI built for the way brokerages actually work, deployed inside the systems your team already uses.
Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 39
- Round size: Seed $532k–$3.1M; Pre-Seed $660k–$1M; Series A $3.2M–$16M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Narchie — Create a home that's uniquely yours with Narchie. Shop sustainably, minimize waste, and find one-of-a-kind homeware items.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
- Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Information Technology
- Stage:Pre-Seed, Seed, Angel
- Geography: France, United States
Investor stats
- Total investments: 20
- Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more...Investment focus
- Industry: Big Data, TV, B2B
- Stage:Seed, Series A, Series C
- Geography: United Kingdom, Germany
Investor stats
- Total investments: 6
- Round size: Series A $26M–$26M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 26
- Round size: Seed $550k–$4.9M; Pre-Seed $902k–$3.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 42
- Round size: Seed $756k–$7M; Pre-Seed $55k–$4.2M; Venture - Series Unknown $2.4M–$34M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Stackfix — Stackfix operates as a software comparison platform.
- Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
- Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Nadav Ben-Chanoch
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 232
- Round size: Seed $500k–$6M; Pre-Seed $120k–$2.5M; Series A $4M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Swaap — We build & operate onchain trading systems. We are a group of scientists and technologists committed to build open systems.
- micro1 — We help companies hire and manage the best software engineers easily.
- Skedway — Skedway connects software, AI, sensors, displays and automation into one intelligent operational layer for the physical workplace.
Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Croatia, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
- Syskit — Syskit Point keeps your Microsoft 365 environment under control - secured, cost-optimized, and AI confident.
Jan Hruska
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 82
- Round size: Seed $1M–$6.9M; Pre-Seed $1.1M–$3.5M; Series A $3.7M–$26M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Otel AI — Otel reads every system your hotel runs on as one hotel, then hands your team each decision with the case already made. Live in days.
- Wassist — Launch your AI sales agent on WhatsApp for Shopify in under 60 seconds. Recover 30-50% of abandoned carts and increase conversions by 3x.
- Capsa AI — Providing next-generation investors with a competitive edge.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, Belgium
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 62
- Round size: Seed $1.7M–$14M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, FinTech
- Stage:Seed, Series A, Series B
- Geography: United States, India, Germany
Investor stats
- Total investments: 34
- Round size: Seed $1.1M–$8M; Series A $11M–$38M; Series B $15M–$150M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Curative — Get on-the-go COVID-19 testing and other essential health services, wherever you are.
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- Mansa — Built by Black creators with a passion for making culture-positive content, Mansa is the only place to stream the best in Global Black stories
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more...Investment focus
- Industry: Software, Gaming, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Denmark, Finland
Investor stats
- Total investments: 81
- Round size: Seed $1M–$8.3M; Pre-Seed $242k–$2.4M; Series A $5.4M–$30M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- ScyAI — Risk intelligence that thinks with you.
- Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
- Flow Engineering — Requirements management, made collaborative
For the last 10+ years, I've had the rare fortune of working with world-class entrepreneurs - as a venture or angel investor, startup team member or growth advisor - in the US and in India. Experience: US VC - Investor @ NEA India VC - Principal & Founding Member @ Lightbox (ex. Kleiner Perkins India and Sherpalo) Startup ops in the US- VP, Bus Dev and early employee @ EverFi (one of the largest edtech networks globally) Startup ops in India - Key leadership responsibilities related to 4 Lightbox companiesCurrently, I am especially spending a large portion of my time on blockchain startups and cryptocurrencies. INVESTING: Lots of learnings from working on early to growth stage investments. US: Millennial Media (IPO, acq. by AOL), OPOWER (IPO, acq. by Oracle), Gilt Groupe (acq. by Saks / Hudson Bay), ChannelAdvisor (IPO), AddThis (acq. by Oracle), EverFi, Suniva, Videology, Credibase, new crypto and blockchain projects India: Droom, Melorra, Paymate, Zoomin, Stalkbuylove, Fynd, The Better India, Mech MochaSTARTUP OPERATIONS: Hands-on experience in both hyper-growth and turnaround situations. Wore a few hats as an early employee and head of BD at EverFi (one of the largest edtech networks globally having served 16MM students and raised $250MM), led strategic finance projects for NEA companies Suniva and AddThis, and interned at InMobi. Owned or helped solve problems across strategy, M&A, senior hiring, int'l expansion and fundraising while working closely with management at Droom, Melorra, Paymate and Zoomin
Show more...Investment focus
- Industry: Financial Services, Software, Information Technology
- Stage:Pre-Seed, Seed, Grant
- Geography: India, United States, Germany
Investor stats
- Total investments: 46
- Round size: Seed $572k–$11M; Pre-Seed $165k–$2M
- Lead/follow: 72% lead, 28% follow
Portfolio highlights
- Klub — India's leading Revenue Based Financing platform with a vision to revolutionize growth capital. Join the Klub for fast, fair & flexible funding.
- StayQrious — StayQrious is an ed-tech startup that focuses on skilling students in computer applications such as coding through online group classes. The company also focuses on collaboration, critical thinking, and creativity through these virtual classrooms.
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Michelle Tempest
Show more...Investment focus
- Industry: Health Care, Cannabis, Life Science
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
- Medwise.ai — Medwise.ai is the Google for doctors.
Sven Fund - Managing Director @ Fullstopp
Show more...Investment focus
- Industry: Publishing, Events, Digital Media
- Stage:Seed, Pre-Seed
- Geography: Germany, Italy, Ireland
Investor stats
- Total investments: 9
- Round size: Seed $250k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- UNFIA — The marketplace of craft wine
- Ex Ordo — Ex Ordo is a Galway-based software company whose web applications enable research conference organisers to manage successful and career-enhancing events at which researchers can publish papers and collaborate together. Their web applications automate the mundane, time-consuming tasks, saving organisers an average of 15 days, €5 to €15k, overthe life of a conference.
- SciFlow — SciFlow is a comprehensive publishing platform that allows researchers to focus on what is important – their research. We offer an intuitive text editor that helps to focus on writing – not formatting – the document. All co-authors can write, comment and review the same version of the article. With our premium services, we allow researchers tocheck for plagiarism and spelling errors and to translate their text. With one click, the article is exported to a publisher compliant format. Unlike existing text editors, researchers can perform all tasks related to publishing scientific texts with SciFlow on a single platform. Thus, SciFlow saves time and gives the confidence to submit an article to a publisher.
Keith is an associate professor of strategic and international management and entrepreneurship at London Business School as well as a senior lecturer at University College London. He also holds various non-executive directorships and advisory roles. His career has spanned academia, consulting, investing and hands-on operational roles withinindustry and the venture capital world.
Show more...Investment focus
- Industry: Software, Gaming, Real Estate
- Stage:Seed, Angel, Pre-Seed
- Geography: United Kingdom, Spain, Portugal
Investor stats
- Total investments: 9
- Round size: Seed $1.4M–$6.5M; Angel $446k–$1.3M; Pre-Seed $721k–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- Connected — Connected is a startup that offers affordable connecting humans, unleashing a new wave of IoT-based business models and contributing to bridge the digital gap.
- Sensible Object — Sensible Object Makes games that combine beautiful things, custom hardware and digital apps into new kinds of play.
Mikael Lonn is an Angel Investor.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
David Lucas
Show more...Investment focus
- Industry: Software, Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in Europe Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!